Press releases

Press release

August 14, 2026

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease

Read more

Press release

August 6, 2026

Lantheus Reports Second Quarter 2026 Financial Results

Read more

Press release

August 3, 2026

Curium Announces Definitive Agreement to Merge with Lantheus

Read more

Press release

July 23, 2026

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time

Read more

Press release

June 26, 2026

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

Read more

Press release

June 3, 2026

Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Read more

Press release

June 2, 2026

Lantheus’ LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year

Read more

Press release

May 27, 2026

Lantheus to Present at the William Blair 46th Annual Growth Stock Conference

Read more

Press release

May 21, 2026

Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting

Read more

For access to press releases before 2022 and full-text search capabilities, please visit our investor site.